Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer

References

• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• RiceTWIshwaranHFergusonMKBlackstoneEHGoldstrawPCancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging PrimerJ Thorac Oncol2017121364227810391
   PubMed Web of Science ®Google Scholar
• SjoquistKMBurmeisterBHSmithersBMAustralasian Gastro-Intestinal Trials GroupSurvival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisLancet Oncol201112768169221684205
   PubMed Web of Science ®Google Scholar
• SugawaraKYamashitaHUemuraYNumeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinomaSurgery2017162484685628739092
   PubMed Web of Science ®Google Scholar
• PengJWangWPDongTRefining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node StationsAnn Thorac Surg2016101128028626381757
   PubMed Web of Science ®Google Scholar
• FuXLiuQLuoKLymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patientsJ Surg Oncol2017116793994628703872
   PubMed Web of Science ®Google Scholar
• WangFZhengYWangZNodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field LymphadenectomyAnn Thorac Surg201710441187119328669504
   PubMed Web of Science ®Google Scholar
• RiceTWIshwaranHHofstetterWLEsophageal Cancer: Associations With (pN+) Lymph Node MetastasesAnn Surg2017265112212928009736
   PubMed Web of Science ®Google Scholar
• WoodSLPernemalmMCrosbiePAWhettonADMolecular histology of lung cancer: from targets to treatmentsCancer Treat Rev201541436137525825324
   PubMed Web of Science ®Google Scholar
• AdesFZardavasDBozovic-SpasojevicILuminal B breast cancer: molecular characterization, clinical management, and future perspectivesJ Clin Oncol201432252794280325049332
   PubMed Web of Science ®Google Scholar
• CiomborKKWuCGoldbergRMRecent therapeutic advances in the treatment of colorectal cancerAnnu Rev Med2015661839525341011
   PubMedGoogle Scholar
• SuHHuNYangHHGlobal gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypesClin Cancer Res20111792955296621385931
   PubMed Web of Science ®Google Scholar
• DelcuveGPKhanDHDavieJRRoles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitorsClin Epigenetics201241522414492
   PubMed Web of Science ®Google Scholar
• ZouHWuYNavreMSangBCCharacterization of the two catalytic domains in histone deacetylase 6Biochem Biophys Res Commun20063411455016412385
   PubMed Web of Science ®Google Scholar
• ZhangYGilquinBKhochbinSMatthiasPTwo catalytic domains are required for protein deacetylationJ Biol Chem200628152401240416272578
   PubMed Web of Science ®Google Scholar
• BaliPPranpatMBradnerJInhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitorsJ Biol Chem200528029267292673415937340
   PubMed Web of Science ®Google Scholar
• ZhangXYuanZZhangYHDAC6 modulates cell motility by altering the acetylation level of cortactinMol Cell200727219721317643370
   PubMed Web of Science ®Google Scholar
• ParmigianiRBXuWSVenta-PerezGHDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulationProc Natl Acad Sci U S A2008105289633963818606987
   PubMed Web of Science ®Google Scholar
• NoguésLRegleroCRivasVG Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 AxisEBioMedicine20161313214527720394
   PubMed Web of Science ®Google Scholar
• AsthanaJKapoorSMohanRPandaDInhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cellsJ Biol Chem201328831225162252623798680
   PubMed Web of Science ®Google Scholar
• WangXXWanRZLiuZPRecent advances in the discovery of potent and selective HDAC6 inhibitorsEur J Med Chem20181431406141829133060
   PubMed Web of Science ®Google Scholar
• JungKHNohJHKimJKHistone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancerHepatology201256264465722392728
   PubMed Web of Science ®Google Scholar
• LiDSunXZhangLHistone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cellsProtein Cell20145321422324474193
   PubMed Web of Science ®Google Scholar
• LinTWChenMTLinLTTDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastomaOncotarget2017834566125662528915616
   PubMedGoogle Scholar
• SeoJMinSKParkHRExpression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the BreastJ Breast Cancer201417432333125548579
   PubMed Web of Science ®Google Scholar
• YangCJLiuYPDaiHYNuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancerOncotarget2015630302633027626388610
   PubMedGoogle Scholar
• HeQLiGWangXA Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric CancerCell Physiol Biochem20174241326133528700998
   PubMedGoogle Scholar
• LiNTieXJLiuPJEffects of down-regulation of HDAC6 expression on proliferation, cell cycling and migration of esophageal squamous cell carcinoma cells and related molecular mechanismsAsian Pac J Cancer Prev201314268568923621219
   PubMedGoogle Scholar
• WenJLuoKJLiuQWThe epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patientsOncotarget2016725375813758827147562
   PubMedGoogle Scholar
• ZhangSSYangHXieXAdjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studiesDis Esophagus201427657458423621119
   PubMed Web of Science ®Google Scholar
• LyuXHuangJMaoYAdjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?J Surg Oncol2014110786486824976079
   PubMed Web of Science ®Google Scholar
• QinRQWenYSWangWPThe role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysisMed Oncol20163343126922662
   PubMed Web of Science ®Google Scholar
• XieXZhangSSWenJPrognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancerBiomarkers201318429730323627614
   PubMed Web of Science ®Google Scholar
• ChenYFXieJDJiangYCThe Prognostic Value of Peripheral Benzodiazepine Receptor in Patients with Esophageal Squamous Cell CarcinomaJ Cancer20178163343335529158807
   PubMed Web of Science ®Google Scholar
• PodlahaORiesterMDeSMichorFEvolution of the cancer genomeTrends Genet201228415516322342180
   PubMed Web of Science ®Google Scholar
• SchrijverWSelenicaPLeeJYMutation profiling of key cancer genes in primary breast cancers and their distant metastasesCancer Res201878123112312129615433
   PubMed Web of Science ®Google Scholar
• SaberAHiltermannTJNKokKMutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumorsCarcinogenesis201738214415127993895
   PubMed Web of Science ®Google Scholar
• KilvaerTKPaulsenEEKhanehkenariMRThe presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survivalBr J Cancer2016114101145115127167450
   PubMed Web of Science ®Google Scholar
• BoninSPracellaDBarbazzaRSulfaroSStantaGIn stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survivalVirchows Arch2015466557158025724181
   PubMed Web of Science ®Google Scholar
• WenJLuoKJHuYYangHFuJHMetastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patientsAnn Surg Oncol20132051668167523429937
   PubMed Web of Science ®Google Scholar
• Aldana-MasangkayGISakamotoKMThe role of HDAC6 in cancerJ Biomed Biotechnol2011201187582421076528
   PubMed Web of Science ®Google Scholar
• SajiSKawakamiMHayashiSSignificance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancerOncogene200524284531453915806142
   PubMed Web of Science ®Google Scholar
• TaoHChenYYSunZWChenHLChenMSilence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90J Cell Biochem201811986623663229665050
   PubMed Web of Science ®Google Scholar
• BatchuSNBrijmohanASAdvaniAThe therapeutic hope for HDAC6 inhibitors in malignancy and chronic diseaseClin Sci (Lond)201613012987100327154743
   PubMed Web of Science ®Google Scholar